◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0928

King International Investment Limited (0928) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-10

King International Investment Limited (0928) operates in the Diagnostics & Research industry and is headquartered in Central, Hong Kong with about 13 employees. Its market capitalization is roughly HKD 185 million. In the fiscal year ended 2026-03-31, 0928 reported HKD 143M in revenue and HKD 2M in net income.

King International Investment Limited, an investment holding company, provides healthcare products and services in the People's Republic of China and Hong Kong.

Interactive charts & full statements →

0928 Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total RevenueHKD 143MHKD 41MHKD 234MHKD 224M
Gross ProfitHKD 25MHKD 13MHKD 38MHKD 12M
Operating Income (EBIT)HKD 9M(HKD 13M)HKD 18M(HKD 32M)
Net IncomeHKD 2M(HKD 48M)HKD 16M(HKD 25M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0928 Free Cash Flow History

0928 Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total AssetsHKD 385MHKD 286MHKD 336MHKD 264M
Total LiabilitiesHKD 147MHKD 64MHKD 70MHKD 31M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0928 viewer.

Other Companies in Diagnostics & Research

← 0927All “0-9” companies0929 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.